To study the effect of heparin within the placenta , we performed secondary analyses on a pilot trial where 32 women with negative thrombophilia screens and second-trimester evidence of placental insufficiency were randomized to standard care or antenatal self-administration of unfractionated heparin ( UFH ) 7500 IU twice-daily .